Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics, Broad to Study Cancer Genomes

NEW YORK (GenomeWeb News) - Complete Genomics will sequence glioblastoma and melanoma samples for the Broad Institute as part of a pilot study the company announced last month.

For the project, Complete Genomics will use its DNA sequencing technology to sequence five samples provided by the Broad Institute. The first genome will be a sample that has already been studied extensively by the scientific community. The other four genomes will include glioblastoma and melanoma samples and their matched normal controls.

"Our newly-released, proof-of-concept sequencing data have been well received by the scientific community and we are now looking forward to demonstrating our technology's potential to reveal new avenues of medical research," Complete Genomics Chairman, President, and CEO Clifford Reid said in a statement.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.